Autobio Diagnostics Co., Ltd. (SHA:603658)
38.85
+0.02 (0.05%)
Oct 27, 2025, 11:29 AM CST
Autobio Diagnostics Revenue
Autobio Diagnostics had revenue of 1.06B CNY in the quarter ending June 30, 2025, a decrease of -4.79%. This brings the company's revenue in the last twelve months to 4.32B, down -4.81% year-over-year. In the year 2024, Autobio Diagnostics had annual revenue of 4.47B with 0.62% growth.
Revenue (ttm)
4.32B
Revenue Growth
-4.81%
P/S Ratio
5.13
Revenue / Employee
749.07K
Employees
5,773
Market Cap
22.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.47B | 27.55M | 0.62% |
| Dec 31, 2023 | 4.44B | 2.03M | 0.05% |
| Dec 31, 2022 | 4.44B | 675.71M | 17.94% |
| Dec 31, 2021 | 3.77B | 787.79M | 26.45% |
| Dec 31, 2020 | 2.98B | 298.70M | 11.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 42.62B |
| WuXi AppTec | 41.90B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |
| Shanghai Fosun Pharmaceutical (Group) | 40.12B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Jiangsu Hengrui Medicine | 30.15B |
| Zhejiang NHU Company | 22.87B |
| Aier Eye Hospital Group | 21.94B |